Health Care & Life Sciences » Biotechnology | Chongqing Zhifei Biological Products Co. Ltd.

Chongqing Zhifei Biological Products Co. Ltd. | Mutual Funds

Mutual Funds that own Chongqing Zhifei Biological Products Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
6,599,941
0.76%
-535,198
2%
12/31/2017
lnvesco Great Wall Domestic Demand Growth II Fund
5,308,324
0.62%
65,805
13.26%
12/31/2017
Fullgoal Tianhui Fund
4,650,402
0.54%
4,650,402
4.38%
12/31/2017
LC New Blue Chip Balanced Fund
4,253,619
0.49%
-2,577,781
4.49%
12/31/2017
LC New Trend Equity Fund
3,180,077
0.37%
-4,537,123
4.88%
12/31/2017
Invesco Great Wall Domestic Demand Growth Fund
2,812,345
0.33%
-33,273
13.33%
12/31/2017
Fullgoal Tianrui Region Fund
2,345,398
0.27%
2,345,398
4.01%
12/31/2017
E Fund Growth Enterprise Index ETF
2,115,309
0.25%
-339,400
2.11%
12/31/2017
2,027,609
0.24%
-692,527
1.93%
12/31/2017
1,813,013
0.21%
-1,496,662
4.94%
12/31/2017

About Chongqing Zhifei Biological Products Co.

View Profile
Address
25th floor, 7 Jinyuan Road
Chongqing Chongqing 400020
China
Employees -
Website http://www.zhifeishengwu.com
Updated 07/08/2019
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.